Dr. Humphrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Se Uglow Ave
Dallas, OR 97338Phone+1 503-623-8376Fax+1 503-623-5293
Education & Training
A.T. Still University, School of Osteopathic Medicine in ArizonaClass of 1985
Certifications & Licensure
OR State License 1987 - 2024
WI State License 1986 - 1993
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 123 citationsNuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell densitySang Hyeon Lee, De Chen, Jeffrey S. Humphrey, James R. Gnarra, W. M. Linehan
Proceedings of the National Academy of Sciences of the United States of America. 1996-03-05 - 131 citationsRandomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: Nati...Natasha B. Leighl, Luis Paz-Ares, Jean-Yves Douillard, Christian Peschel, Andrew Arnold
Journal of Clinical Oncology. 2005-04-20 - 61 citationsReduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.A. Craig Lockhart, Rod D. Braun, Daohai Yu, Joel R. Ross, Mark W. Dewhirst
Clinical Cancer Research. 2003-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
